INEGY 10 MG20 MG TABLETS

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
EZETIMIBE; SIMVASTATIN
Available from:
MERCK SHARP & DOHME ISRAEL LTD
ATC code:
C10AA01
Pharmaceutical form:
TABLETS
Composition:
SIMVASTATIN 20 MG; EZETIMIBE 10 MG
Administration route:
PER OS
Prescription type:
Required
Manufactured by:
MERCK SHARP & DOHME B.V., THE NETHERLANDS
Therapeutic group:
SIMVASTATIN
Therapeutic area:
SIMVASTATIN
Therapeutic indications:
Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH.Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).
Authorization number:
136 57 31315 00
Authorization date:
2012-04-30

Similar products

Search alerts related to this product

Share this information